Wave Life Sciences WVE
NASDAQ WVE
$3.41 -0.07 (-2.02%)
As of: Nov 10, 2026 · 3:59 PM EST

Wave Life Sciences (WVE) Preferred Shares (2014)

Updated

Wave Life Sciences' Preferred Shares came in at $7.87 million for Q4 2014.

Analysis

Wave Life Sciences (WVE) Preferred Shares (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Wave Life Sciences 715.80 Mn -1.23 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 7.87 Mn
API Access

Wave Life Sciences Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=WVE&period=max&api_key=YOUR_API_KEY